Rotenone Beyond Just An Insecticide: A Review
DOI:
https://doi.org/10.37591/rrjot.v4i2.1306Abstract
Pesticides have received the most attention due to their global application and widespread implications on human health. In recent years, both epidemiological and toxicological studies have provided evidence that pesticides have the potential to act as toxicants contributing to the development of pathogenesis such as neuronal degenerations as well as may be utilized to induce signalling for reversal, suppress or prevent carcinogenic progression. Rotenone, an isoflavones naturally found in the roots and stems of several plants, is used as a broad-spectrum pesticide. Surprisingly, being a known toxicant, rotenone is used in organic food farming, based on its label as a natural product. Highly lipophilic, it easily crosses the cellular membrane without depending on a transmembrane protein. Once inside the cell, it accumulates at mitochondrial complex I where it is known to inhibit the transfer of electrons and increases reactive oxygen species (ROS) production, causing oxidative damage to DNA and proteins. More recently, rotenone was also shown to inhibit proteosome activity and catalyze the degradation of ubiquitin tagged proteins which may be implicated in pathogenesis of diseases. Numerous plant derived flavonoids compounds, with mitochondrial electron transport chain interrupter, such as rotenone, are currently used by cancer patients as dietary supplements to complement chemotherapy. Excess generation of ROS and its involvement in down-regulation of cellular proliferation by rotenone may be significant in chemotherapeutic assistance in prolonged treatment of tumourigenesis in future.
Keywords: Rotenone, Reactive oxygen species (ROS), Cancer, Mitochondrial dysfunction
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |